|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 38/28 | (2006.01) |
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 2918286 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15161696.8 |
| Date of filing the European patent application | 2005-10-05 | |
| (97) | Date of publication of the European application | 2015-09-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-18 |
| (46) | Date of publication of the claims translation | 2020-04-10 |
| (30) | Number | Date | Country code |
| 200401519 | 2004-10-05 | DK |
| (72) |
Berglund, Petter, DK
Hammelev, Charlotte, DK
Eskildsen, Lone, DK
Madsen, Johanne, DK
Olsen, Helle Aalund, DK
Kimer, Lone Logstrup, DK
|
| (73) |
Novo Nordisk A/S,
Corporate Patents Novo Allé, 2880 Bagsvęrd,
DK
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinis preparatas, kurio sudėtyje yra kristalinės ir taip pat ištirpintos formos insulino |
| PHARMACEUTICAL PREPARATION CONTAINING INSULIN IN CRYSTALLINE AS WELL AS IN SOLUBILIZED FORM |
| Payment date | Validity (years) | Amount | |
| 2024-09-19 | 347.00 EUR |